CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $16,000 | -38.5% | 13,950 | -3.3% | 0.01% | -33.3% |
Q2 2022 | $26,000 | -10.3% | 14,424 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $29,000 | -29.3% | 14,424 | -4.5% | 0.01% | -25.0% |
Q4 2021 | $41,000 | -42.3% | 15,099 | -4.7% | 0.02% | -51.5% |
Q3 2021 | $71,000 | -22.8% | 15,849 | 0.0% | 0.03% | -21.4% |
Q2 2021 | $92,000 | -17.1% | 15,849 | 0.0% | 0.04% | -48.1% |
Q1 2021 | $111,000 | +46.1% | 15,849 | 0.0% | 0.08% | +97.6% |
Q4 2020 | $76,000 | – | 15,849 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |